Skip to content

Manjishtadi Anjana For Shushkakshipak (Dry Eye Disease)

An Open Randomised Controlled Clinical Trial Evaluating The Efficacy Of Manjishtadi Anjana in Shushkakshipak - Nil

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/12/099130
Enrollment
76
Registered
2025-12-15
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H00-H59- Diseases of the eye and adnexa Health Condition 2: H578- Other specified disorders of eye and adnexa Health Condition 3: H578- Other specified disorders of eye and adnexa Health Condition 4: H578- Other specified disorders of eye and adnexa Health Condition 5: H579- Unspecified disorder of eye and adnexa

Interventions

None listed

Sponsors

Dr Sneha Raju Pujari
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients suffering from symptoms of shuskakshipak (Netrashushkata, Daha ,Gharsha, Aavildarshanam, Krichronmeelanimeelana, etc.) 2.Patients of age group between 18-55yrs irrespective gender. 3.Patients having excessive outdoowork exposed to sunlight for more than 3hrs. 4.Patients having IT profession, those who have screen time more than 3 hrs. 5.Patients willing to take part in treatment.

Exclusion criteria

Exclusion criteria: Patient having any congenital eye anomaly.Patient having occular disease or infection.Patient having history of immediate ocular surgery.Patient refuse to continue treatment.

Design outcomes

Primary

MeasureTime frame
Manjishtadi Anjana is effective in management of ShushkakshipakTimepoint: 7 Days

Secondary

MeasureTime frame
Mahaoushadhi Anjana is effective in management of ShushkakshipakTimepoint: 7 days

Countries

India

Contacts

Public ContactDr Jayavant Vasant Kharat

Hon Shri Annasaheb Dange Ayurved Medical College And Research Centre Ashta Sangali

jayvantkharat55@gmail.com09604010037

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026